Daymark Health has filed a notice of an exempt offering of securities to raise $26 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Daymark Health is raising up to $26,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Daymark Health
Daymark Health is a cancer care company that partners with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Our mission is to transform the cancer care experience by delivering personalized, world-class care when and where patients need it most. Our community-based team of nurses, nurse practitioners, social workers, and Health Partners works to address the clinical, mental health, and social needs, offering care navigation, 24/7 support, mental health assistance, symptom management, and social support all delivered virtually and in the home.
To learn more about Daymark Health, visit https://www.daymarkhealth.com/
Daymark Health Linkedin Page: https://www.linkedin.com/company/daymarkhealth/
Contact:
Justin Bekelman, Chief Executive Officer
254-315-0338
https://www.linkedin.com/in/bekelman/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
